overlay landing page

We have 314 Active Angel Investors investing in Oncology on Angels Partners

main investor picture
Albert Oliveras
Investing in Other • IT (& TMT) • BioTe...
 Barcelona Catalonia, Spain
Investor Picture
Previous Investments
  • • Scytl: $12780000 (Later stage VC)
  • • Sanifit: $81290000 (Later stage VC)
  • • Peptomyc: $13690000 (Later stage VC)
  • • Minoryx Therapeutics:
  • • Premiumguest: $500000 (Seed Round)
  • • ARTHEx Biotech: $40600000 (Series B)
  • • Gyala Therapeutics: $3000000 (Venture Round)
  • • ARTHEx Biotech: $42000000 (Series B)
  • • Telomere Therapeutics: $1500000 (Seed Round)
  • • ARTHEx Biotech: $4300000 (Seed Round)
  • • Telum Therapeutics: $4100000 (Seed Round)
  • • Gyala Therapeutics: $1500000 (Seed Round)
  • • Pulmobiotics: $2000000 (Seed Round)
  • • ARTHEx Biotech: $1500000 (Seed Round)
  • • Telum Therapeutics: $18000000 (Series A)
  • • Gyala Therapeutics S.L.: $3000000 (Venture Round)
  • • Gyala Therapeutics S.L.: $1500000 (Seed Round)

Albert Oliveras

Barcelona Catalonia, Spain

Contact this investors  
Investing In

Other • IT (& TMT) • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Advertising • Impact • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology

Description

Albert Ferrer is the Founding Partner at Invivo Ventures.

main investor picture
Carl Erickson
Investing in Software (Web Marketplace Saas..) &b...
 Michigan Ann Arbor, M..., United States
Investor Picture
Previous Investments
  • • Unum ID: $2000000 (Seed Round)
  • • Mader Mill, Inc: (early stage)
  • • Envoy B2B: (mid stage)
  • • Local Orbit:
  • • Tappan Hill Ventures: (early stage)
  • • Varsity News Network:
  • • Blue Medora: (early stage)
  • • Atomic Object LLC: (early stage)

Carl Erickson

Michigan Ann Arbor, Michigan, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Hardware (& Manufacturing) • Entertainment (& Sports) • Healthcare (& Wellness) • Life Science • Oncology

Description

Founder and Chairman at Atomic Object

Founder and Chairman at Atomic Object

main investor picture
Adele Oliva
Investing in Software (Web Marketplace Saas..) &b...
 Bay Area, U.S.A.
Investor Picture
Previous Investments
  • • Interpace Biosciences: $20000000 (Later stage VC)
  • • Solsys Medical: $19000000 (Later stage VC)
  • • Centurion Service Group:
  • • Vesper Medical: $15460000 (Later stage VC)

Adele Oliva

Bay Area, U.S.A.

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • HealthTech (& Fitness) • Developer tools • Medical Devices (& Hospital Services) • Life Science • Oncology • Consumer

Description

Current Data Partnerships Lead at OpenAI, formerly at Redpoint Ventures, Ares, and Dorm Room Fund

main investor picture
David Malm
Investing in Software (Web Marketplace Saas..) &b...
 Waltham Massachusetts..., U.S.A.
Investor Picture
Previous Investments
  • • Brighton Home Health and Hospice (Utah operations):

David Malm

Waltham Massachusetts - Massachusetts - U.S.A., U.S.A.

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) • Logistics (& Distribution) • Life Science • Oncology

main investor picture
David Lowe
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Califor..., Canada
Investor Picture
Previous Investments
  • • Shattuck Labs: $46620000 (Later stage VC)

David Lowe

San Francisco California - Waltham Massachusetts - Walnut California - - Texas - Toronto Ontario Canada - Ontario Canada, Canada

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Businesses Solutions • FinTech (& Financials services) • HealthTech (& Fitness) • Food & Beverage • Medical Devices (& Hospital Services) • Life Science • Oncology

Description

Dr. David Lowe is a Co-Founder of Aeglea BioTherapeutics Holdings. He also served as Chief Executive Officer at Aeglea BioTherapeutics. He is a Board Member at Shattuck Labs. He is a Board Member at MaRS Innovation.. Previously, he srved as managing director at Skyline Ventures. Dr. Lowe joined Skyline Ventures in 2002 and became a partner at Skyline in 2003. Prior to joining Skyline, Dr. Lowe was employed at Genentech, a biotherapeutics company, from 1985 to 2001, where he led drug discovery activities in biologics and small molecule therapeutics. Dr. Lowe held various positions while at Genentech including Director of Cardiovascular Research. Dr. Lowe currently serves on the Boards of Directors of Applied Genetics Technologies Corporation, Proteon Therapeutics, and ARCA Discovery. Dr. Lowe holds B.S. and Ph.D. degrees in biochemistry from the University of Toronto, Canada

main investor picture
Roxanne Varza
Investing in Software (Web Marketplace Saas..) &b...
 Paris Ile - de, France
Investor Picture
Previous Investments
  • • Spore Biotechnologies: $8000000 (Pre Seed Round)
  • • Augment: $5500000 (Seed Round)
  • • Escape: $3600000 (Seed Round)
  • • Reflect: $2000000 (Pre Seed Round)
  • • Revyze: $2000000 (Seed Round)
  • • Dance: $16500000 (Series A)
  • • Claap: $3000000 (Pre Seed Round)
  • • Onepilot: $1500000 (Seed Round)
  • • Resilience: $5000000 (Seed Round)
  • • Moka.care: $2500000 (Seed Round)

Roxanne Varza

Paris Ile - de, France

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Education • Businesses Solutions • Retail (& E-Commerce) • A.I. (& Big Data) • Mobile Apps • Real Estate (& Construction) • Healthcare (& Wellness) • Oncology

Description

Roxanne Varza is currently Director of STATION F, the biggest startup campus in the world with more than 1,000 startups, located in Paris. She is also an angel investor (companies include Claap, Folk, Resilience.care, Moka.care, Colette and more) and scout for Sequoia Capital (and was previously a scout at Atomico).Before joining STATION F, sheled Microsoft Ventures Paris and was Editor of TechCrunch France. She also worked for several London-based startups and cofounded StarHer (now part of SISTA), Tech.eu and Failcon France. She has also been a member of the French Government's Conseil National du Numérique (CNNum) and the European Commission's European Innovation Council (EIC).Roxanne is trilingual and holds degrees from UCLA, Sciences Po Paris and the London School of Economics.

main investor picture
Ilya Nykin
Investing in Software (Web Marketplace Saas..) &b...
 New Jersey Saint Loui..., United States
Investor Picture
Previous Investments
  • • Benson Hill: $159090000 (Later stage VC)
  • • bioClarity: $18710000 (Later stage VC)
  • • Revive Kombucha: (late stage)
  • • CareDox, Inc.: (mid stage)
  • • ThinOPTICS: (mid stage)
  • • Spindrift Beverage: (mid stage)
  • • Zeel Networks: (early stage)
  • • Plum Organics: (early stage)
  • • Divergence:
  • • Prolog Ventures: (early stage)
  • • BioPolymerix:
  • • Metaphase Design:
  • • Metaphase Ophthalmic:
  • • Ivy Technologies:

Ilya Nykin

New Jersey Saint Louis, Missouri, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Education • Logistics (& Distribution) • Healthcare (& Wellness) • Life Science • Oncology

Description

Co-founder and Managing Director at Prolog Ventures

Co-founder and Managing Director at Prolog Ventures

main investor picture
Thomas Clozel
Investing in Software (Web Marketplace Saas..) &b...
 New York City, U.S.A.
Investor Picture
Previous Investments
  • • Callyope: $2200000 (Seed Round)
  • • Osium AI: $2400000 (Seed Round)
  • • Resilience: $5000000 (Seed Round)
  • • Spot - justspot.io: (Seed Round)
  • • Patch Biosciences: (Seed Round)

Thomas Clozel

New York City, U.S.A.

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • A.I. (& Big Data) • Mobile Apps • Healthcare (& Wellness) • Oncology

Description

Thomas Clozel co-founded Owkin with Gilles Wainrib and serves as Chief Executive Officer. Mr. Clozel attended Weill Medical College of Cornell University and Icahn School of Medicine at Mount Sinai.

main investor picture
Ben Kong
Investing in Software (Web Marketplace Saas..) &b...
 Dubai , United Arab E..., U.S.A.
Investor Picture
Previous Investments
  • • Zilliqa Basis AELF Oasis kadena:
  • • Radian: (Pre Seed)
  • • Excision BioTherapeutics: $750000 (Seed)
  • • Volumetric: $2000000 (Seed)
  • • MAIA Biotechnology: $2000000 (Seed)
  • • Relativity Space: $140000000 (Series C)
  • • Zengo: (Seed)
  • • OncoSenX: $3000000 (Pre Seed)
  • • Coinbase: $300000000 (Series E)
  • • Algorand: (Series Unknown)
  • • Oasis Labs: $45000000 (Series Unknown)
  • • Arweave: $9000000 (Seed)
  • • Oisin Biotechnologies: (Seed)

Ben Kong

Dubai - United Arab Emirates, U.S.A.

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • A.I. (& Big Data) • Blockchain (& Cryptos) • Aerospace (& Defense) • DeepTech • Healthcare (& Wellness) • Oncology • 3D Printing

Description

Limited Partner at Rebel Fund

main investor picture
    Stephen Haakenson
    Investing in BioTech • HealthTech (& Fitness...
     Michigan , Kalamazoo ..., U.S.A.
    Investor Picture
    Previous Investments
    • • GreenMark Biomedical: $500000 (Seed Round)

    Stephen Haakenson

    Michigan - Kalamazoo Michigan - U.S.A., U.S.A.

    Contact this investors  
    Investing In

    BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science • Oncology

    main investor picture
    Yi Shi
    Investing in Other • Education • BioTec...
     Shanghai China, China
    Investor Picture
    Previous Investments
    • • Hangzhou Just Biotherapeutics (Just China): $400000000 (Later stage VC)
    • • Transcenta Holding: $100000000 (Later stage VC)
    • • Gritstone oncology: $93000000 (Later stage VC)
    • • NextCure: $93000000 (Later stage VC)
    • • CanSino Biologics: $65000000 (Later stage VC)
    • • TP Therapeutics: $45000000 (Later stage VC)
    • • Veritas Genetics: $30000000 (Later stage VC)
    • • Abbisko Therapeutics: $28000000 (Early stage VC)
    • • ReadCoor, Inc.: $23000000 (Early stage VC)
    • • Singlera Genomics: $20000000 (Early stage VC)
    • • InventisBio: $19000000 (Later stage VC)
    • • Fortis Therapeutics: $18000000 (Early stage VC)
    • • Landspace Technology: (early stage)
    • • NewsDog: (early stage)
    • • DTEN (DisplayTen): (early stage)
    • • Livestar: (early stage)
    • • Smartisan Technology Co., Ltd.:
    • • Artefact:
    • • DotC United Group: (early stage)
    • • Reality Squared Games: (mid stage)
    • • UniCareer: (early stage)
    • • Zeus Entertainment Group:

    Yi Shi

    Shanghai China, China

    Contact this investors  
    Investing In

    Other • Education • BioTech • IoT (& Wearables) • HealthTech (& Fitness) • Gaming (& eSports) • Medical Devices (& Hospital Services) • Investment Management • Life Science • Oncology • Pharmaceutical (& Medicine) • Woman Focused

    Description

    serial entrepreneur

    serial entrepreneur

    main investor picture
      Daniel S Janney
      Investing in Software (Web Marketplace Saas..) &b...
       San Francisco California, U.S.A.
      Investor Picture
      Previous Investments
      • • Lottery.com: $2320000
      • • St. George's University: $750000000 (Other)
      • • Vir Biotechnology: $150000000 (Later stage VC)
      • • Allakos: $100000000 (Later stage VC)
      • • Egenesis: $100000000 (Later stage VC)
      • • CuraSen: $54500000 (Later stage VC)
      • • VertiFlex: $40000000 (Later stage VC)
      • • eGenesis: $38000000 (Early stage VC)
      • • DispatchHealth: $30800000 (Later stage VC)
      • • GenePeeks: $16000000 (Later stage VC)
      • • Virobay: $8000000 (Later stage VC)
      • • Healthstat:

      Daniel S Janney

      San Francisco California, U.S.A.

      Contact this investors  
      Investing In

      Software (Web Marketplace Saas..) • IT (& TMT) • Businesses Solutions • Investment Management • Life Science • Oncology

      Description

      Daniel Janney serves as Managing Director at Alta Partners. He joined Alta immediately following the firm's founding in 1996, and was a co-founder of the Alta BioPharma effort. Dan focuses on investments in biopharmaceutical products and therapeutics. He has been directly involved in the funding and development of over 25 life sciences companies. Dan is, or has served on the board of directors of a number of companies, including Alba Therapeutics, Allakos, DiscoveRx, Esperion Therapeutics, Evolve BioSystems, Lithera, Prolacta Bioscience, Sutro Biopharma and ViroBay. In addition, he led Alta's investments in ChemGenex Pharmaceuticals, CoTherix, Definity Health, Dynavax, Endonetics, Ilex Oncology, InterMune, LJL Biosystems and Mako Surgical. Prior to joining Alta, he was a senior investment banker at Montgomery Securities, focusing on life sciences companies. Dan is also a member of The President's Council of the Gladstone Institutes. He holds a Bachelor of Arts in History from Georgetown University and a Master of Business Administration from the Anderson School at the University of California, Los Angeles.

      How to connect with Angel Investors in the Oncology industry?

      In the Oncology industry, angel investors such as Vinod Khosla, Esther Dyson, and Steve Jurvetson are highly active. These investors focus on startups offering innovative solutions in cancer treatment, diagnostics, and research. Vinod Khosla, founder of Khosla Ventures, invests in oncology startups that have the potential to significantly advance cancer care and treatment outcomes. Esther Dyson, an entrepreneur and investor, looks for companies that leverage technology to improve cancer diagnostics and patient care. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups with strong scientific foundations and impactful oncology solutions. To connect with these investors, attend oncology conferences, medical expos, and networking events such as ASCO Annual Meeting, World Cancer Congress, and AACR Annual Meeting. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your oncology solution addresses key challenges, such as improving cancer diagnostics, enhancing treatment efficacy, or advancing research. Highlight any traction you’ve gained, such as partnerships with medical institutions, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as product sales, licensing, or research grants, will further strengthen your pitch. Leveraging endorsements or case studies from oncology experts can also enhance your credibility.

      Join the community!
      Connect with investors & startup founders

      Comprehensive Guides to Finding Angel Investors

      By clicking on "Create Account" you accept our terms of service

      Already have an account?
      Login
      Mike testimonial

      Michael Colin - Founder of The MVMT



      "We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

      Taylor Testimonial

      Taylor Matter - Founder & CEO, Hurdle Apparel



      "Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who invested $200,000 in our brand."

      founder clement

      Clément Perrot - Co-Founder & CEO of Prynt



      "Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


      Create An Account
      Copyright © 2026 - All trademarks and copyrights belong to their respective owners.
      proof notifcation
      32 New StartupsStarted their fundraisingover the last 7 days